@oana-sandulescu.bsky.social
ID Prof Dr at Carol Davila University and NIID Matei Bals
@oana-sandulescu.bsky.socialJust back from a PhD committee at @uio.no 🎓
Impressive RCT of ~20,000 participants showed: #HEV vaccine safe in adults but should be avoided before and during early pregnancy.
And the timing: just a day after the Nobel Prize in Medicine announcement!
@eswinfluenza.bsky.socialReposted by @oana-sandulescu.bsky.social🗓️ 🕒 Save the date for #ESWI2027: The largest European-based influenza conference returns for its 11th edition in Valencia, 26-29 September 2027. Subscribe to our newsletter to be the first to receive updates: eswi.org/form/newslet...
@oana-sandulescu.bsky.social🍄 #BalkanFungus in 🇷🇴 - landmark meeting for #MedicalMycology
I shared an update on #cryptococcus, from screening and early recognition to diagnosis & management. Early diagnosis can make all the difference 💙
Congratulations @efisg-escmid.bsky.social and the amazing Cluj team!
@esgvh.bsky.socialReposted by @oana-sandulescu.bsky.socialChronic liver disease can be destabilised by #influenza and other respiratory infections. Honored that our #ESGVH Chair, Prof. @oana-sandulescu.bsky.social joins the #ESWI Board to connect liver health, vaccination and respiratory prevention.
@escmid.bsky.social
@eswinfluenza.bsky.social
@oana-sandulescu.bsky.socialA new #EUCIC #IPC cohort in Ljubljana 💫
Fantastic evolution in a program we were piecing together several years ago.
#AMS take-home:
Tailor your ab choice. Your AMS plan.
To your country. Your setting. Your patient.
Evidence travels. Good stewardship adapts.
@escmid.bsky.social
@eucic.bsky.social
@oana-sandulescu.bsky.socialTruly honored to join #ESWI and to be part of such an exceptional group of board members&experts.
Looking forward to contributing my expertise and exchanging ideas to advance influenza science and public health.
Grateful for the opportunity. Excited for the work ahead.
@eswinfluenza.bsky.social
@esgvh.bsky.socialReposted by @oana-sandulescu.bsky.socialHonoured and proud that our Chair, Prof. @oana-sandulescu.bsky.social delivered a fantastic keynote at #ESCV2026 in Porto!
“Practical ART decision-making in HIV-HBV coinfection” - a timely reminder that HBV status matters in ART decisions.
#HIV #HBV
@escvirology.bsky.social
@escmid.bsky.social
@oana-sandulescu.bsky.socialFriday morning = keynote time at #ESCV2026 in Porto!
My keynote: Practical ART decision-making in HIV-HBV coinfection
4 patient trajectories
4 ART decisions
4 things to know
The message? HBV matters.
Thank you @escvirology.bsky.social 👏👏
@esgvh.bsky.social
@escmid.bsky.social
@esgvh.bsky.socialReposted by @oana-sandulescu.bsky.social⏰ TIME TO REGISTER!
🌍 Major international experts in viral hepatitis - all in one place.
Join ESGVH for 3 days covering hepatitis A–E, emerging viruses & challenging cases.
📅 27–29 Nov 2026 | 💻 Online
👉 Register now lnkd.in/e53ChGBN
@esgvh.bsky.socialReposted by @oana-sandulescu.bsky.socialStarting in 3 hours!
Join us:
HCV Elimination: A Multi-society Perspective on Progress, Gaps and Next Steps
📅 10 September 2026
⏰ 3 pm CEST
💻 Zoom
🔗 Participation is free.
Register here:
lnkd.in/e577hvey
@aasldnews.bsky.social
@idsainfo.bsky.social
@inhsu.bsky.social
@escmid.bsky.social
@oana-sandulescu.bsky.socialA thought to carry into autumn 🍂
At #ESC2026, I was invited to discuss the cardioprotective role of high-dose flu vaccination for the elderly.
A great example of ID&cardio shared responsibility for the same patient.
Flu prevention is also CV prevention 💉❤️
@escardio.bsky.social
@medscape.com